Acupuncture therapy for bronchial asthma: an overview of systematic reviews_Chinese Journal of Evidence-Based Medicine

Authors：

LIU Yilin , XU Guixing , HUANG Liuyang , TIAN Hao , ZHOU Zhuo , HUANG Fengyuan ,  LIANG Fanrong

Chengdu University of Traditional Chinese Medicine, Chengdu 610075, P. R. China;

Corresponding?author：

LIANG Fanrong, Email: acuresearch@126.com

Keywords：

Acupuncture therapy; Bronchial asthma; Overview of systematic reviews; AMSTAR 2; GRADE

DOI：

10.7507/1672-2531.202201010

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective To evaluate the quality of methodology and evidence of the systematic reviews and meta-analyses (SRs/MAs) of acupuncture therapy for bronchial asthma. Methods CNKI, CBM, VIP, WanFang Data, PubMed, The Cochrane Library and Web of Science databases were electronically searched to collect SRs/MAs of acupuncture therapy for bronchial asthma from inception to October 31, 2021. Four reviewers independently screened literature, extracted data, and applied the AMSTAR 2 to evaluate the quality of methodology of the included studies and the GRADE system to assess the certainty of evidence for outcomes. Results A total of 14 SRs/MAs were included and their main conclusions were that acupuncture therapy was beneficial in improving the clinical efficacy of bronchial asthma treatment. The evaluation of AMSTAR 2 showed that the methodological quality of all studies was all extremely low. The evidence grading of GRADE system showed that, in the total of 59 outcomes, 7 were graded as medium-level, 24 as low-level, 28 as extremely low-level, and none was graded as high-level. Conclusion The current evidence shows the advantages of acupuncture therapy for bronchial asthma but the reliability of SRs/MAs is low. High-quality clinical studies are still needed to verify the efficacy of acupuncture therapy for bronchial asthma.

Citation： LIU Yilin, XU Guixing, HUANG Liuyang, TIAN Hao, ZHOU Zhuo, HUANG Fengyuan, LIANG Fanrong. Acupuncture therapy for bronchial asthma: an overview of systematic reviews. Chinese Journal of Evidence-Based Medicine, 2022, 22(8): 955-963. doi: 10.7507/1672-2531.202201010 Copy

1.	趙霞, 汪受傳, 韓新民, 等. 小兒哮喘中醫診療指南. 中醫兒科雜志, 2008, 4(3): 4-6.
2.	GBD 2015 Chronic Respiratory Disease Collaborators. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: a systematic analysis for the global burden of disease study 2015. Lancet Respir Med, 2017, 5(9): 691-706.
3.	李為民, 羅汶鑫. 我國慢性呼吸系統疾病的防治現狀. 西部醫學, 2020, 32(1): 1-4.
4.	Barnes PJ. New therapies for asthma: is there any progress. Trends Pharmacol Sci, 2010, 31(7): 335-343.
5.	Bleecker ER, Menzies-Gow AN, Price DB, et al. Systematic literature review of systemic corticosteroid use for asthma management. Am J Respir Crit Care Med, 2020, 201(3): 276-293.
6.	中華醫學會呼吸病學分會哮喘病組. 支氣管哮喘防治指南(2020年版). 中華結核和呼吸雜志, 2020, 43(12): 1023-1048.
7.	Xu YD, Cui JM, Wang Y, et al. Proteomic analysis reveals the deregulation of inflammation-related proteins in acupuncture-treated rats with asthma onset. Evid Based Complement Alternat Med, 2012, 2012: 850512.
8.	Xu YD, Wei Y, Wang Y, et al. Exogenous S100A8 protein inhibits PDGF-induced migration of airway smooth muscle cells in a RAGE-dependent manner. Biochem Biophys Res Commun, 2016, 472(1): 243-249.
9.	王宇, 孫婧, 金融, 等. 針刺對哮喘大鼠氣道重建模型氣道平滑肌細胞T型鈣通道蛋白表達的影響. 中國針灸, 2012, 32(6): 534-540.
10.	邵素菊, 權春分, 邵素霞, 等. “邵氏五針法”治療急性發作期哮病: 多中心隨機對照研究. 中國針灸, 2013, 33(9): 774-778.
11.	陶歡, 楊樂天, 平安, 等. 隨機或非隨機防治性研究系統評價的質量評價工具AMSTAR2解讀. 中國循證醫學雜志, 2018, 18(1): 101-108.
12.	張方圓, 沈傲梅, 曾憲濤, 等. 系統評價方法學質量評價工具AMSTAR2解讀. 中國循證心血管醫學雜志, 2018, 10(1): 14-18.
13.	Guyatt HG, Oxman DA, Vist G, 等. GRADE指南: Ⅳ. 證據質量分級—研究的局限性(偏倚風險). 中國循證醫學雜志, 2011, 11(4): 456-463.
14.	Guyatt HG, Oxman DA, Kunz R, 等. GRADE指南: Ⅶ. 證據質量評價—不一致性. 中國循證醫學雜志, 2011, 11(12): 1444-1451.
15.	Guyatt HG, Oxman DA, Kunz R, 等. GRADE指南: Ⅷ. 證據質量評價—間接性. 中國循證醫學雜志, 2011, 11(12): 1452-1458.
16.	Guyatt HG, Oxman DA, Kunz R, 等. GRADE指南: Ⅵ. 證據質量評價—不精確性(隨機誤差). 中國循證醫學雜志, 2011, 11(12): 1435-1443.
17.	Guyatt HG, Oxman DA, Montori V, 等. GRADE指南: Ⅴ. 證據質量評價—發表偏倚. 中國循證醫學雜志, 2011, 11(12): 1430-1434.
18.	章榮, 任凱. 穴位埋線治療支氣管哮喘的系統評價. 醫學信息(醫藥版), 2009, (2): 4.
19.	于璐, 張燕, 陳程, 等. 針灸治療哮喘隨機對照臨床研究文獻Meta分析. 中國針灸, 2010, 30(9): 787-792.
20.	胡成想, 李素荷. 穴位埋線療法治療支氣管哮喘的系統評價. 安徽中醫藥大學學報, 2014, 33(3): 70-73.
21.	張賽男, 王煦喆, 陳果, 等. 穴位埋線治療支氣管哮喘的臨床研究文獻Meta分析. 針灸臨床雜志, 2016, 32(10): 74-78.
22.	陳新宇, 舒華, 吳治諺, 等. 熱敏灸治療支氣管哮喘臨床療效的系統評價. 針灸臨床雜志, 2016, 32(5): 51-55.
23.	李孟媛, 王洪峰, 王朝輝. 針灸治療支氣管哮喘臨床研究文獻的Meta分析. 時珍國醫國藥, 2018, 29(8): 2046-2048.
24.	陳曉東, 居尚, 童畫, 等. 自血療法治療哮喘病療效的系統評價及Meta分析. 長春中醫藥大學學報, 2019, 35(1): 58-61.
25.	梁汝圣, 遠穎. 穴位埋線治療咳嗽變異性哮喘的Meta分析. 中國城鄉企業衛生, 2020, 35(3): 7-12.
26.	Shen FY, Lee MS, Jung SK. Effectiveness of pharmacopuncture for asthma: a systematic review and meta-analysis. Evid Based Complement Alternat Med, 2011, 2011: 678176.
27.	Xiong J, Liu Z, Chen R, et al. Effectiveness and safety of heat-sensitive moxibustion on bronchial asthma: a meta-analysis of randomized control trials. J Tradit Chin Med, 2014, 34(4): 392-400.
28.	Bang M, Chang S, Kim JH, et al. Pharmacopuncture for asthma: a systematic review and a meta-analysis of randomized controlled trials. Eur J Integr Med, 2017, 11: 6-17.
29.	Cui W, Sun W, Mao YQL, et al. Evaluation of catgut implantation at acupoints for asthma: a systematic review and meta-analysis. Trad Med Modern Med, 2018, 1(2): 123-132.
30.	Jiang C, Jiang L, Qin Q. Conventional treatments plus acupuncture for asthma in adults and adolescent: a systematic review and meta-analysis. Evid Based Complement Alternat Med, 2019, 2019: 9580670.
31.	Xiong J, Qi W, Yang H, et al. Acupuncture treatment for cough-variant asthma: a meta-analysis. Evid Based Complement Alternat Med, 2021, 2021: 6694936.
32.	Cook DJ, Mulrow CD, Haynes RB. Systematic reviews: synthesis of best evidence for clinical decisions. Ann Intern Med, 1997, 126(5): 376-380.
33.	葉靜, 李涓, 周俊, 等. 針灸治療腦卒中后肩手綜合征的meta分析的再評價. 中國康復醫學雜志, 2020, 35(2): 189-194.
34.	Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. J Pharmacol Pharmacother, 2010, 1(2): 100-107.
35.	MacPherson H, Altman DG, Hammerschlag R, et al. Revised standards for reporting interventions in clinical trials of acupuncture (STRICTA): Extending the CONSORT statement. J Evid Based Med, 2010, 3(3): 140-155.
36.	銀子涵, 徐桂興, 楊晗, 等. 針灸治療帶狀皰疹及其后遺癥的系統評價再評價. 世界科學技術-中醫藥現代化, 2020, 22(8): 2772-2779.
37.	崔學超, 王剛. 針刺治療支氣管哮喘研究進展. 中國呼吸與危重監護雜志, 2013, 12(4): 416-422.
38.	周新, 張旻. 中國支氣管哮喘防治指南(2020年版)解讀. 診斷學理論與實踐, 2021, 20(2): 138-143.

1. 趙霞, 汪受傳, 韓新民, 等. 小兒哮喘中醫診療指南. 中醫兒科雜志, 2008, 4(3): 4-6.
2. GBD 2015 Chronic Respiratory Disease Collaborators. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: a systematic analysis for the global burden of disease study 2015. Lancet Respir Med, 2017, 5(9): 691-706.
3. 李為民, 羅汶鑫. 我國慢性呼吸系統疾病的防治現狀. 西部醫學, 2020, 32(1): 1-4.
4. Barnes PJ. New therapies for asthma: is there any progress. Trends Pharmacol Sci, 2010, 31(7): 335-343.
5. Bleecker ER, Menzies-Gow AN, Price DB, et al. Systematic literature review of systemic corticosteroid use for asthma management. Am J Respir Crit Care Med, 2020, 201(3): 276-293.
6. 中華醫學會呼吸病學分會哮喘病組. 支氣管哮喘防治指南(2020年版). 中華結核和呼吸雜志, 2020, 43(12): 1023-1048.
7. Xu YD, Cui JM, Wang Y, et al. Proteomic analysis reveals the deregulation of inflammation-related proteins in acupuncture-treated rats with asthma onset. Evid Based Complement Alternat Med, 2012, 2012: 850512.
8. Xu YD, Wei Y, Wang Y, et al. Exogenous S100A8 protein inhibits PDGF-induced migration of airway smooth muscle cells in a RAGE-dependent manner. Biochem Biophys Res Commun, 2016, 472(1): 243-249.
9. 王宇, 孫婧, 金融, 等. 針刺對哮喘大鼠氣道重建模型氣道平滑肌細胞T型鈣通道蛋白表達的影響. 中國針灸, 2012, 32(6): 534-540.
10. 邵素菊, 權春分, 邵素霞, 等. “邵氏五針法”治療急性發作期哮病: 多中心隨機對照研究. 中國針灸, 2013, 33(9): 774-778.
11. 陶歡, 楊樂天, 平安, 等. 隨機或非隨機防治性研究系統評價的質量評價工具AMSTAR2解讀. 中國循證醫學雜志, 2018, 18(1): 101-108.
12. 張方圓, 沈傲梅, 曾憲濤, 等. 系統評價方法學質量評價工具AMSTAR2解讀. 中國循證心血管醫學雜志, 2018, 10(1): 14-18.
13. Guyatt HG, Oxman DA, Vist G, 等. GRADE指南: Ⅳ. 證據質量分級—研究的局限性(偏倚風險). 中國循證醫學雜志, 2011, 11(4): 456-463.
14. Guyatt HG, Oxman DA, Kunz R, 等. GRADE指南: Ⅶ. 證據質量評價—不一致性. 中國循證醫學雜志, 2011, 11(12): 1444-1451.
15. Guyatt HG, Oxman DA, Kunz R, 等. GRADE指南: Ⅷ. 證據質量評價—間接性. 中國循證醫學雜志, 2011, 11(12): 1452-1458.
16. Guyatt HG, Oxman DA, Kunz R, 等. GRADE指南: Ⅵ. 證據質量評價—不精確性(隨機誤差). 中國循證醫學雜志, 2011, 11(12): 1435-1443.
17. Guyatt HG, Oxman DA, Montori V, 等. GRADE指南: Ⅴ. 證據質量評價—發表偏倚. 中國循證醫學雜志, 2011, 11(12): 1430-1434.
18. 章榮, 任凱. 穴位埋線治療支氣管哮喘的系統評價. 醫學信息(醫藥版), 2009, (2): 4.
19. 于璐, 張燕, 陳程, 等. 針灸治療哮喘隨機對照臨床研究文獻Meta分析. 中國針灸, 2010, 30(9): 787-792.
20. 胡成想, 李素荷. 穴位埋線療法治療支氣管哮喘的系統評價. 安徽中醫藥大學學報, 2014, 33(3): 70-73.
21. 張賽男, 王煦喆, 陳果, 等. 穴位埋線治療支氣管哮喘的臨床研究文獻Meta分析. 針灸臨床雜志, 2016, 32(10): 74-78.
22. 陳新宇, 舒華, 吳治諺, 等. 熱敏灸治療支氣管哮喘臨床療效的系統評價. 針灸臨床雜志, 2016, 32(5): 51-55.
23. 李孟媛, 王洪峰, 王朝輝. 針灸治療支氣管哮喘臨床研究文獻的Meta分析. 時珍國醫國藥, 2018, 29(8): 2046-2048.
24. 陳曉東, 居尚, 童畫, 等. 自血療法治療哮喘病療效的系統評價及Meta分析. 長春中醫藥大學學報, 2019, 35(1): 58-61.
25. 梁汝圣, 遠穎. 穴位埋線治療咳嗽變異性哮喘的Meta分析. 中國城鄉企業衛生, 2020, 35(3): 7-12.
26. Shen FY, Lee MS, Jung SK. Effectiveness of pharmacopuncture for asthma: a systematic review and meta-analysis. Evid Based Complement Alternat Med, 2011, 2011: 678176.
27. Xiong J, Liu Z, Chen R, et al. Effectiveness and safety of heat-sensitive moxibustion on bronchial asthma: a meta-analysis of randomized control trials. J Tradit Chin Med, 2014, 34(4): 392-400.
28. Bang M, Chang S, Kim JH, et al. Pharmacopuncture for asthma: a systematic review and a meta-analysis of randomized controlled trials. Eur J Integr Med, 2017, 11: 6-17.
29. Cui W, Sun W, Mao YQL, et al. Evaluation of catgut implantation at acupoints for asthma: a systematic review and meta-analysis. Trad Med Modern Med, 2018, 1(2): 123-132.
30. Jiang C, Jiang L, Qin Q. Conventional treatments plus acupuncture for asthma in adults and adolescent: a systematic review and meta-analysis. Evid Based Complement Alternat Med, 2019, 2019: 9580670.
31. Xiong J, Qi W, Yang H, et al. Acupuncture treatment for cough-variant asthma: a meta-analysis. Evid Based Complement Alternat Med, 2021, 2021: 6694936.
32. Cook DJ, Mulrow CD, Haynes RB. Systematic reviews: synthesis of best evidence for clinical decisions. Ann Intern Med, 1997, 126(5): 376-380.
33. 葉靜, 李涓, 周俊, 等. 針灸治療腦卒中后肩手綜合征的meta分析的再評價. 中國康復醫學雜志, 2020, 35(2): 189-194.
34. Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. J Pharmacol Pharmacother, 2010, 1(2): 100-107.
35. MacPherson H, Altman DG, Hammerschlag R, et al. Revised standards for reporting interventions in clinical trials of acupuncture (STRICTA): Extending the CONSORT statement. J Evid Based Med, 2010, 3(3): 140-155.
36. 銀子涵, 徐桂興, 楊晗, 等. 針灸治療帶狀皰疹及其后遺癥的系統評價再評價. 世界科學技術-中醫藥現代化, 2020, 22(8): 2772-2779.
37. 崔學超, 王剛. 針刺治療支氣管哮喘研究進展. 中國呼吸與危重監護雜志, 2013, 12(4): 416-422.
38. 周新, 張旻. 中國支氣管哮喘防治指南(2020年版)解讀. 診斷學理論與實踐, 2021, 20(2): 138-143.

Previous Article
Hospital-based health technology assessment: a bibliometric analysis
Next Article
Surrogate endpoint: definition evolution, evaluation and validation

Chinese Journal of Evidence-Based Medicine

Acupuncture therapy for bronchial asthma: an overview of systematic reviews

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content